Different changes of plasma membrane β-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol

Life Sciences

Volumn 81, Issue 5, 2007, Pages 399-404

  Horinouchi, Takahiro ^a,b,c   Morishima, Shigeru ^a   Tanaka, Takashi ^a   Suzuki, Fumiko ^a   Tanaka, Yoshio ^b   Koike, Katsuo ^b   Miwa, Soichi ^c   Muramatsu, Ikunobu ^a  

^a Faculty of Medicine   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

adrenoceptor antagonists (propranolol; atenolol, bevantolol); mRNA; Plasma membrane adrenoceptors; Rat heart; Tissue segment binding method

Indexed keywords

ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR; BEVANTOLOL; MESSENGER RNA; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG RECEPTOR BINDING; HEART; HEART VENTRICLE; MALE; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; UPREGULATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ATENOLOL; MALE; PROPANOLAMINES; PROPRANOLOL; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 34447506194     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.06.003     Document Type: Article

References (23)

1. Baker S.P., and Katovich M.J. Chronic propranolol treatment decreases cardiac β-adrenoceptors in spontaneously hypertensive rats. British Journal of Pharmacology 78 (1982) 479-482
2. Baker S.P., and Potter L.T. Effect of propranolol on β-adrenoceptors in rat hearts. British Journal of Pharmacology 68 (1980) 8-10
3. Bouzamondo A., Hulot J.S., Sanchez P., Cucherat M., and Lechat P. Beta-blocker treatment in heart failure. Fundamental and Clinical Pharmacology 15 (2001) 95-109
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-254
5. Brodde O.-E., and Michel M.C. Adrenergic and muscarinic receptors in the human heart. Pharmacological Reviews 51 (1999) 651-689
6. 1-adrenoceptor subtypes. Molecular Pharmacology 61 (2002) 1008-1016
7. Dupre D.J., Robitaille M., Ethier N., Villeneuve L.R., Mamarbachi A.M., and Hebert T.E. Seven transmembrane receptor core signaling complexes are assembled prior to plasma membrane trafficking. The Journal of Biological Chemistry 281 (2006) 34561-34573
8. Frishman W.H., Goldberg R.J., and Benfield P. Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris. Drugs 35 (1988) 1-21
9. Glaubiger G., and Lefkowitz R.J. Elevated β-adrenergic receptor number after chronic propranolol treatment. Biochemical Biophysical Research Communications 78 (1977) 720-725
10. Haeusler G. Pharmacology of β-blockers: classical aspects and recent developments. Journal of Cardiovascular Pharmacology 16 (1990) S1-S9
11. Hiraizumi-Hiraoka Y., Tanaka T., Yamamoto H., Suzuki F., and Muramatsu I. Identification of α-1L adrenoceptor in rabbit ear artery. Journal of Pharmacology and Experimental Therapeutics 310 (2004) 995-1002
12. Horinouchi T., Morishima S., Tanaka T., Suzuki F., Tanaka Y., Koike K., and Muramatsu I. Pharmacological evaluation of plasma membrane β-adrenoceptors in rat hearts using the tissue segment binding method. Life Sciences 79 (2006) 941-948
13. 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP. Naunyn-Schmiedeberg's Archives of Pharmacology 344 (1991) 56-69
14. Madden K.M., Levy W.C., and Stratton J.R. Normal aging impairs upregulation of the β-adrenergic but not the α-adrenergic response: aging and adrenergic upregulation. Journal of Cardiovascular Pharmacology 48 (2006) 153-159
15. 1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices. Journal of Molecular and Cellular Cardiology 41 (2006) 441-450
16. Morishima S., Tanaka T., Yamamoto H., Suzuki F., Akino H., Yokoyama O., and Muramatsu I. Identification of alpha-1L and alpha-1A adrenoceptors in human prostate by tissue segment binding. The Journal of Urology 177 (2007) 377-381
17. Muramatsu I., Tanaka T., Suzuki S., Zhang L., Hiraizumi-Hiraoka Y., Anisuzzaman A.S.M.D., Yamamoto H., Horinouchi T., and Morishima S. Tissue segment binding method - a powerful tool for pharmacome analysis of native receptors. Journal of Pharmacological Sciences 98 (2005) 331-339
18. Reiter M.J. Cardiovascular drug class specificity: β-blockers. Progress in Cardiovascular Diseases 47 (2004) 11-33
19. 4-adrenoceptor' in rat atrium. British Journal of Pharmacology 123 (1998) 371-380
20. Takita M., Kigoshi S., and Muramatsu I. Effects of bevantolol hydrochloride on immobilization stress-induced hypertension and central β-adrenoceptors in rats. Pharmacology Biochemistry and Behavior 45 (1993) 623-627
21. Takita M., Oda Y., Kigoshi S., and Muramatsu I. Effects of propranolol and atenolol on immobilization stress-induced hypertension and down-regulation of central β-adrenoceptors in rats. Pharmacology Biochemistry and Behavior 50 (1995) 225-232
22. Tanaka T., Zhang L., Suzuki F., and Muramatsu I. Alpha-1 adrenoceptors: evaluation of receptor subtype binding-kinetics in intact arterial tissues and comparison with membrane binding. British Journal of Pharmacology 141 (2004) 468-476
23. 3H-CGP12177 to β-adrenoceptors in rat myocardial membranes. Japanese Journal of Pharmacology 49 (1989) 11-19